JAZZ | Jazz Pharmaceuticals Plc |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.54 |
Leverage | 65.97% |
Market Cap | $ 7.7B |
PE | 16.79 |
Dividend Yield | 0.00% |
Profit | $ 459.3m |
Margin | 11.60% |
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.